Literature DB >> 24333123

Virus-free transient protein production in Sf9 cells.

Xiao Shen1, David L Hacker1, Lucia Baldi1, Florian M Wurm2.   

Abstract

A method for virus-free transient gene expression from suspension-adapted Sf9 insect cells was developed with the gene of interest being expressed from a plasmid carrying the homologous region 5 enhancer (hr5) and the immediate early 1 (ie1) promoter from Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV). Under the optimal conditions described in the study, cells were transfected at a density of 30×10⁶ cells/mL with 0.9 μg DNA and 1.35 μg of linear 25 kD polyethylenimine (PEI) per million cells. Following transfection, the culture was diluted to 4×10⁶ cells/mL for the protein production phase. The volumetric yield of tumor necrosis factor receptor (ectodomain) fused to an Fc domain (TNFR-Fc) was about 100 μg/mL for cultures at volumes up to 300 mL. As expected, the molecular weight of the dimeric TNFR-Fc produced from Sf9 cells was about 6 kDa less than that produced from a recombinant Chinese hamster ovary (CHO) cell line due to differences in glycosylation between the two hosts. Transient transfection provides an alternative to the baculovirus expression vector system (BEVS) for the rapid production of recombinant proteins from Sf9 cells.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Polyethylenimine; Recombinant protein; Sf9 cells; Suspension culture; Transient gene expression

Mesh:

Substances:

Year:  2013        PMID: 24333123     DOI: 10.1016/j.jbiotec.2013.11.018

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  8 in total

1.  Transient Expression and Cellular Localization of Recombinant Proteins in Cultured Insect Cells.

Authors:  Jeffrey A Fabrick; J Joe Hull
Journal:  J Vis Exp       Date:  2017-04-20       Impact factor: 1.355

2.  Fast plasmid based protein expression analysis in insect cells using an automated SplitGFP screen.

Authors:  Maren Bleckmann; Stefan Schmelz; Christian Schinkowski; Andrea Scrima; Joop van den Heuvel
Journal:  Biotechnol Bioeng       Date:  2016-03-10       Impact factor: 4.530

3.  Recombinant production of human α2-macroglobulin variants and interaction studies with recombinant G-related α2-macroglobulin binding protein and latent transforming growth factor-β2.

Authors:  Laura Marino-Puertas; Laura Del Amo-Maestro; Marta Taulés; F Xavier Gomis-Rüth; Theodoros Goulas
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

Review 4.  Production of virus-like particles for vaccines.

Authors:  J Fuenmayor; F Gòdia; L Cervera
Journal:  N Biotechnol       Date:  2017-08-01       Impact factor: 5.079

5.  Baculovirus-free insect cell expression system for high yield antibody and antigen production.

Authors:  Janin Korn; Dorina Schäckermann; Toni Kirmann; Federico Bertoglio; Stephan Steinke; Janyn Heisig; Maximilian Ruschig; Gertrudis Rojas; Nora Langreder; Esther Veronika Wenzel; Kristian Daniel Ralph Roth; Marlies Becker; Doris Meier; Joop van den Heuvel; Michael Hust; Stefan Dübel; Maren Schubert
Journal:  Sci Rep       Date:  2020-12-07       Impact factor: 4.379

6.  Genomic Analysis and Isolation of RNA Polymerase II Dependent Promoters from Spodoptera frugiperda.

Authors:  Maren Bleckmann; Markus H-Y Fritz; Sabin Bhuju; Michael Jarek; Margitta Schürig; Robert Geffers; Vladimir Benes; Hüseyin Besir; Joop van den Heuvel
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

7.  Transfection of insect cell in suspension for efficient baculovirus generation.

Authors:  S Roest; S Kapps-Fouthier; J Klopp; S Rieffel; B Gerhartz; B Shrestha
Journal:  MethodsX       Date:  2016-05-04

8.  Identification of Essential Genetic Baculoviral Elements for Recombinant Protein Expression by Transactivation in Sf21 Insect Cells.

Authors:  Maren Bleckmann; Margitta Schürig; Fang-Fang Chen; Zen-Zen Yen; Nils Lindemann; Steffen Meyer; Johannes Spehr; Joop van den Heuvel
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.